Subscribe
Contact Us
About Us
Advertise
Home
News
News from MM&M
Off the Wire
Newsletters
PMD Profiles
Agency Creative Showcase
Publication Connection
PMD Marketplace
Careers
About Us
Additional Resources
MM&M
MM&M Jobs
MAHF
Voi Consulting
Advertise
Subscribe
Get Listed
Additional Resources
RSS
|
Login
|
Register
Business
Pfizer to cut 6,000 jobs
May 18, 2010
Pfizer plans to discontinue operations at several manufacturing plants
Eisai Expands into Canada
May 10, 2010
Establishes New Subsidiary to Market Products to Patients
LEO Pharma Officially Launches in the United States
January 19, 2010
The U.S. operation will market the company's psoriasis franchise
Sciele Pharma, Inc., a Shionogi Group Company, Announces Name Change
January 11, 2010
Further Expands and Strengthens the Presence of "Shionogi" in the U.S. Market
New Merck Begins Operations
November 04, 2009
With Robust Pipeline, Broader Product Portfolio and Expanded Global Presence
SciClone Announces Corporate Restructuring and Workforce Reduction
October 28, 2009
SciClone will cut workforce by 17%
Metabasis Therapeutics Announces the Resignation of Mark Erion, Ph.D., Metabasis' President, CEO & CSO
September 01, 2009
Dr. Erion leaves Metabasis to join Merck & Co., Inc.
Raptor Pharmaceuticals Raises $5 Million
August 25, 2009
Net proceeds to fund programs for its late-stage drug product candidates
SciClone Pharmaceuticals Announces Appointment of Jon S. Saxe as Chairman of Board of Directors
July 30, 2009
Dean S. Woodman Continues as Board Member
Sciele Pharma, a Shionogi Company, Terminates Agreement to Acquire Victory Pharma, Inc.
July 10, 2009
Sciele will continue to focus on its growth and diversification strategy
OSI Pharmaceuticals Announces Consolidation of U.S. Operations
July 07, 2009
The Company Purchases 43 Acre Site in New York
Somaxon Announces $6 Million Private Equity Financing
July 07, 2009
The Acceptance of NDA Resubmission of Silenor® for the Treatment of Insomnia
CyDex Pharmaceuticals Adds Industry Veteran to Accelerate Product Commercialization Initiatives
July 06, 2009
Richard G. White Appointed Vice President of Business Development and Marketing
Myriad Pharmaceuticals, Inc. Established as an Independent Pharmaceutical Development Company
July 01, 2009
Company Will Advance Three Clinical Development Programs in Oncology and Infectious Disease
Spectranetics Names Jason Hein Senior VP, Sales, Marketing and Product Development
June 25, 2009
Appointment Consolidates Leadership of Vascular Intervention and Lead Management Businesses
Takeda Completes Acquisition of IDM Pharma, Inc.
June 24, 2009
Acquisition Adds MEPACT® to Takeda's Oncology Portfolio
Hollis-Eden Pharmaceuticals Announces Appointment of Dr. James M. Frincke President and CEO
June 15, 2009
Dr. Frincke was also elected to the company's board of directors
Procter & Gamble names McDonald to Succeed CEO Lafley
June 10, 2009
Lafley stays on as Chairman
Akorn Announces Management Changes
June 09, 2009
Appoints Raj Rai as Interim Chief Executive Officer
CSL Limited and Talecris Biotherapeutics Agree to Terminate Merger Agreement
June 08, 2009
Federal Trade Commission (FTC) blocks transaction
Genzyme Completes Transaction with Bayer HealthCare
June 02, 2009
Assumes Primary Responsibility for Alemtuzumab in Multiple Sclerosis; Expands Hematologic Oncology Portfolio
Depomed Names Shay Weisbrich Vice President of Marketing
June 01, 2009
Ms. Weisbrich has over 30 years of extensive experience in U.S. and global pharmaceutical companies
Agios Pharmaceuticals Appoints David Schenkein, M.D. as CEO and Duncan Higgons as COO
May 27, 2009
Industry Leaders Bring Deep Oncology and Company Building Experience
Takeda Commences Cash Tender Offer for All Outstanding Shares of IDM Pharma, Inc.
May 26, 2009
The completion of the tender offer is subject to customary closing conditions
Marty J. Duvall Joins Abraxis BioScience as Senior Vice President, Global Marketing and International Commercial Operations
May 22, 2009
Mr. Duvall most recently served as Chief Business Officer of Morphotek
Keryx Biopharmaceuticals Announces Appointment of Ron Bentsur as Chief Executive Officer
May 20, 2009
Mr. Bentsur served as CEO of XTL Biopharmaceuticals
Cephalon Acquires Controlling Interest in Arana Therapeutics
May 20, 2009
Cephalon now has a relevant interest in more than 50 percent of Arana shares
Simulations Plus Appoints Michael Pelekis, Ph.D., Director for Business Development
May 19, 2009
New Position to Focus on Acquisitions and Collaborations
Carl Hull Becomes Chief Executive Officer of Gen-Probe
May 18, 2009
Hank Nordhoff Now Non-Executive Chairman of the Board
Sciele Pharma, a Shionogi Company, to Acquire Victory Pharma, Inc., a U.S. Specialty Pharmaceutical Company
May 18, 2009
Acquisition Provides an Immediate Presence in the U.S. Pain Market
Latest News
Sinobiomed Announces New Chief Executive Officer
Actavis Receives FDA Approval of Atomoxetine HCl Capsules
MonoSol Rx Announces Reckitt Benckiser FDA Approval of Suboxone® Sublingual Film for Treatment of Opioid Dependence
Biodel Announces Name Change for Lead Product Candidate
Pfizer to Acquire FoldRx Pharmaceuticals
GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
pSivida Announces Iluvien® Receives FDA Priority Review for Treatment of Diabetic Macular Edema
Medicis Announces Approval of Additional Strengths of Solodyn(R)
Meda acquires Alaven, a US specialty pharma company
Luminex Announces Commercial Launch of New Cystic Fibrosis Test
Most Popular
Most Emailed
Most Recent
Luminex Announces Commercial Launch of New Cystic Fibrosis Test
Novartis receives FDA approval of Tekamlo
Meda acquires Alaven, a US specialty pharma company
XenoPort Announces Changes to Executive Team
Actavis Receives FDA Approval of Atomoxetine HCl Capsules
GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
Pfizer to Acquire FoldRx Pharmaceuticals
Medicis Announces Approval of Additional Strengths of Solodyn(R)
pSivida Announces Iluvien® Receives FDA Priority Review for Treatment of Diabetic Macular Edema
MonoSol Rx Announces Reckitt Benckiser FDA Approval of Suboxone® Sublingual Film for Treatment of Opioid Dependence
Meda acquires Alaven, a US specialty pharma company
Novo Nordisk Creates 'App' to Help Doctors Dose Insulin, Supporting New Trend in Diabetes Care
Biodel Announces Name Change for Lead Product Candidate
GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
Medicis Announces Approval of Additional Strengths of Solodyn(R)
FDA Accepts Sanofi Pasteur's Application to Expand Indication of Menactra® Vaccine to Infants and Toddlers
Sinobiomed Announces New Chief Executive Officer
Actavis Receives FDA Approval of Atomoxetine HCl Capsules
Pfizer to Acquire FoldRx Pharmaceuticals
MonoSol Rx Announces Reckitt Benckiser FDA Approval of Suboxone® Sublingual Film for Treatment of Opioid Dependence
Sinobiomed Announces New Chief Executive Officer
Actavis Receives FDA Approval of Atomoxetine HCl Capsules
MonoSol Rx Announces Reckitt Benckiser FDA Approval of Suboxone® Sublingual Film for Treatment of Opioid Dependence
Biodel Announces Name Change for Lead Product Candidate
Pfizer to Acquire FoldRx Pharmaceuticals
GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
pSivida Announces Iluvien® Receives FDA Priority Review for Treatment of Diabetic Macular Edema
Medicis Announces Approval of Additional Strengths of Solodyn(R)
Meda acquires Alaven, a US specialty pharma company
Luminex Announces Commercial Launch of New Cystic Fibrosis Test
Popular Topics
Acquisition
Agency
Animal Health
Biopharmaceutical
Biotech
Business
Clinical Management
Collaboration
Diagnostic
Marketing & Communications
Medical Device
Medical Equipment
Merger
New Hire
New Hires
Personnel
Pharmaceutical
Pharmaceutical Products
Pipeline
Product Acquisition
Product Launch
Product Promotion
Regulatory
Regulatory Approval
Research & Development